Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed. The news comes just over a week after Aurora divulged that it and Reliva had agreed to the acquisition. Read More...
Aurora Cannabis Acquisition of Reliva Closes
Aurora Cannabis’ (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed. The news comes just over a week after Aurora divulged that it and Reliva had agreed to the acquisition.
Add Comment